John H.J. Wokke

Affiliations: 
Neurology Utrecht University, Utrecht, Netherlands 
Area:
Neuromuscular disorders
Website:
https://profs.library.uu.nl/index.php/profrec/getprofdata/2409/516/529/0
Google:
"Johannes Hendricus Josephus (John) Wokke"
Mean distance: 16.55 (cluster 48)
 
SNBCP

Parents

Sign in to add mentor
Willem-Hendrik Gispen grad student 1988 Utrecht
Frans G.I. Jennekens grad student 1988 Utrecht
 (Remodelling of the human end plate. Histological observations in aging and disease)

Children

Sign in to add trainee
Leonard van den Berg grad student 1995 Utrecht (Microtree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Voermans NC, de Visser M, Wokke JH, et al. (2013) [Increased CK activity in serum without symptoms: further investigations often unnecessary]. Nederlands Tijdschrift Voor Geneeskunde. 157: A6315
Linssen WH, de Voogt WG, Krahn M, et al. (2013) Long-term follow-up study on patients with Miyoshi phenotype of distal muscular dystrophy. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 20: 968-74
Beauverd M, Mitchell JD, Wokke JH, et al. (2012) Recombinant human insulin-like growth factor I (rhIGF-I) for the treatment of amyotrophic lateral sclerosis/motor neuron disease. The Cochrane Database of Systematic Reviews. 11: CD002064
van der Beek NA, de Vries JM, Hagemans ML, et al. (2012) Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study. Orphanet Journal of Rare Diseases. 7: 88
de Vries JM, van der Beek NA, Hop WC, et al. (2012) Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study. Orphanet Journal of Rare Diseases. 7: 73
Wadman RI, Bosboom WM, van der Pol WL, et al. (2012) Drug treatment for spinal muscular atrophy types II and III. The Cochrane Database of Systematic Reviews. 4: CD006282
Wadman RI, Bosboom WM, van der Pol WL, et al. (2012) Drug treatment for spinal muscular atrophy type I. The Cochrane Database of Systematic Reviews. 4: CD006281
Wadman RI, Bosboom WM, van den Berg LH, et al. (2011) Drug treatment for spinal muscular atrophy types II and III. The Cochrane Database of Systematic Reviews. CD006282
Wadman RI, Bosboom WM, van den Berg LH, et al. (2011) Drug treatment for spinal muscular atrophy type I. The Cochrane Database of Systematic Reviews. CD006281
Visser NA, Braun KP, Leijten FS, et al. (2011) Magnesium treatment for patients with refractory status epilepticus due to POLG1-mutations. Journal of Neurology. 258: 218-22
See more...